These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23328247)

  • 1. Current recommendations for cervical cancer screening: do they render the annual pelvic examination obsolete?
    Kauffman RP; Griffin SJ; Lund JD; Tullar PE
    Med Princ Pract; 2013; 22(4):313-22. PubMed ID: 23328247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No. 385-Indications for Pelvic Examination.
    Evans D; Goldstein S; Loewy A; Altman AD
    J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do new guidelines and technology make the routine pelvic examination obsolete?
    Westhoff CL; Jones HE; Guiahi M
    J Womens Health (Larchmt); 2011 Jan; 20(1):5-10. PubMed ID: 21194307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New cervical cancer screening guidelines, again.
    Karjane N; Chelmow D
    Obstet Gynecol Clin North Am; 2013 Jun; 40(2):211-23. PubMed ID: 23732026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should the annual pelvic examination go the way of annual cervical cytology?
    MacLaughlin KL; Faubion SS; Long ME; Pruthi S; Casey PM
    Womens Health (Lond); 2014 Jul; 10(4):373-84. PubMed ID: 25259899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Potentially Unnecessary Bimanual Pelvic Examinations and Papanicolaou Tests Among Adolescent Girls and Young Women Aged 15-20 Years in the United States.
    Qin J; Saraiya M; Martinez G; Sawaya GF
    JAMA Intern Med; 2020 Feb; 180(2):274-280. PubMed ID: 31904768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
    Melinte-Popescu A; Costăchescu G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Annual Gynecologic Examination Updated for the 21st Century.
    Cappiello J; Levi A
    Nurs Womens Health; 2016; 20(3):315-9. PubMed ID: 27287359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Jun; 156(12):880-91, W312. PubMed ID: 22711081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can self vaginal douching for high risk HPV screening replace or assist efficacy of cervical cancer screening?
    Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
    Asian Pac J Cancer Prev; 2010; 11(5):1397-401. PubMed ID: 21198300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
    Perkins RB; Anderson BL; Gorin SS; Schulkin JA
    Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of screening and treatment of cervical dyskaryosis in Germany.
    Petry KU; Breugelmans JG; Bénard S; Lamure E; Littlewood KJ; Hillemanns P
    Eur J Gynaecol Oncol; 2008; 29(4):345-9. PubMed ID: 18714567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
    Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
    Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer screening in the era of human papillomavirus testing and vaccination.
    Murphy J; Mark H
    J Midwifery Womens Health; 2012; 57(6):569-576. PubMed ID: 23050698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present standards for cervical cancer screening.
    O'Meara AT
    Curr Opin Oncol; 2002 Sep; 14(5):505-11. PubMed ID: 12192269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
    Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
    J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening: Less testing, smarter testing.
    Jin XW; Sikon A; Yen-Lieberman B
    Cleve Clin J Med; 2011 Nov; 78(11):737-47. PubMed ID: 22049541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
    Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening among women without a cervix.
    Sirovich BE; Welch HG
    JAMA; 2004 Jun; 291(24):2990-3. PubMed ID: 15213211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine-based HPV testing as a method to screen for cervical cancer.
    Fontenot HB
    Nurs Womens Health; 2015; 19(1):59-65. PubMed ID: 25690816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.